Oct 18 (Reuters) - Mayne Pharma Group Ltd (MYX) :
- QTRLY REVENUE OF $A92.3 MILLION, AN INCREASE OF 35% ON Q4 23
- EXPECT TO DELIVER POSITIVE OPERATING CASH FLOW FOR FY24.
- EXPECTS CASH GENERATION FROM OPERATIONS TO IMPROVE MOVING INTO SECOND HALF OF YEAR
- EXPECTS ALL THREE BUSINESS SEGMENTS TO DELIVER POSITIVE CONTRIBUTION MARGIN IN FY24
News: MYX Mayne Pharma Group Posts Qtrly Revenue Of A$92.3 Million
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.99 |
Change
-0.090(1.77%) |
Mkt cap ! $405.4M | |||
| Open | High | Low | Value | Volume |
| $5.05 | $5.05 | $4.99 | $1.254M | 250.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 22359 | $4.98 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.08 | 2631 | 2 |
View Market Depth
| Last trade - 16.11pm 08/08/2025 (20 minute delay) ? |
| MYX (ASX) Chart |